Breast positioning during image acquisition is one of the most important yet difficult aspects of breast cancer detection. Evidence suggests that technical issues are responsible for delays in diagnosing 22% of screen-detected cancers and 35% of interval breast cancers1. Despite the success of the MQSA-EQUIP program to improve and standardize the quality of mammographic imaging, poor positioning remains the most common reason for technical failure of ACR clinical image quality review2.
In this lively panel discussion, we examine why radiologists must insist on well positioned, properly exposed mammograms, and the importance of working in partnership with their technologists to optimise image quality. Our panelists include Dr. Randy Hicks, CEO of Regional Medical Imaging - one of the leading women’s imaging centers in the U.S., and Prof. Ruud Pijnappel, CEO of the LRCB, the Dutch Expert Center for Breast Screening and the world’s leading independent authority on quality assurance and optimization of screening programmes.These leaders will share their lessons learned and discuss what value they believe AI can bring to the acquisition of mammography images.
We will also be joined by Mary Beth Chalk. As a breast cancer survivor, Mary Beth will help us better understand the life-changing importance of correct breast positioning - and what artificial intelligence would have meant to her breast screening experience.
Dr. Randy Hicks, MD, MBA - CEO, Regional Medical Imaging
Dr. Ruud Pijnappel, MD, PhD - Professor of Radiology, CEO, LRCB
Dr. Christopher Austin, MD, MSc - Chief Medical Officer, Kheiron Medical Technologies
Mary Beth Chalk - Patient & Public Involvement Leader, Kheiron Medical Technologies
1 American Journal of Roentgenology. 2017;209: 1419-1425. 10.2214/AJR.16.17522
2 FDA.gov, Poor Positioning Responsible For Most Clinical Image Deficiencies, Failures, http://bit.ly/3eR52wN